HIPEC addition to SCS did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer patients. Both SCS alone and SCS with HIPEC groups exhibited similar safety profiles, ...
—–In an interview with MedPage Today, Dr. Kapoor, from the Department of Pain Management at Cleveland Clinic, discusses the role of implantation of a permanent neuromodulation device in management of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results